Stem cells for diabetic kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a type of stem cell called mesenchymal stromal cells (Amimestrocel) can help people with diabetic kidney disease. It aims to see if the treatment is safe and can improve kidney function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have type 2 diabetes.
- You have been diagnosed with diabetic kidney disease through a kidney biopsy in the past 10 years.
- Your urine protein levels are very high (3.5 grams or more per day, or your urine albumin-to-creatinine ratio is over 1000 mg/g).
- Your kidney function is still at least 15 ml/min/1.73m² (based on a common test called eGFR).
- Your blood pressure is controlled to 160/100 mmHg or lower.
- Your recent blood sugar control (HbA1c) is less than 9%.
- You are willing to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It may slow down kidney damage and improve kidney function.
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
This trial tests a treatment called remote ischemic conditioning, which uses brief blood pressure cuff inflations on your arm or leg to help protect your kidneys. It might slow down kidney damage in people with diabetes and kidney disease.
This study tests whether a goal-directed treatment plan using several medications can lower the risk of kidney and heart problems for people with diabetes and kidney disease. It aims to help you manage your condition more effectively.
This study tests a special type of stem cell treatment called mesenchymal stromal cells (Amimestrocel) for patients with acute kidney injury. The goal is to see if this treatment can help kidneys recover better than standard care.
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
Hear when a new Diabetic Kidney Disease (DKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.